TRAF3

TRAF3

Overview

```mermaid
flowchart TD
classDef gene fill:#0a1f0a,stroke:#4caf50
classDef protein fill:#0a1929,stroke:#2196f3
classDef disease fill:#2d0f0f,stroke:#e91e63
classDef pathway fill:#3e2200,stroke:#ff9800
classDef mechanism fill:#1a0a1f,stroke:#9c27b0
classDef therapeutic fill:#e0f2f1,stroke:#009688
TRAF3["TRAF3"] -->|"implicated_in"| neurodegeneration["neurodegeneration"]
TRAF3["TRAF3"] -.->|"inhibits"| TLR4["TLR4"]
TRAF3["TRAF3"] -.->|"inhibits"| CAT["CAT"]
TRAF3["TRAF3"] -.->|"inhibits"| Inflammation["Inflammation"]
TRAF3["TRAF3"] ==>|"activates"| Diabetes["Diabetes"]
TRAF3["TRAF3"] -->|"associated_with"| Tumor["Tumor"]
TRAF3["TRAF3"] -.->|"inhibits"| Ms["Ms"]
TRAF3["TRAF3"] -->|"regulates"| Toll_Like_Receptor["Toll-Like Receptor"]
TRAF3["TRAF3"] -.->|"inhibits"| Oxidative_Stress["Oxidative Stress"]
TRAF3["TRAF3"] -.->|"inhibits"| Nf__b["Nf-Kb"]
TRAF3["TRAF3"] -.->|"inhibits"| TLR["TLR"]
TRAF3["TRAF3"] -.->|"inhibits"| UBIQUITIN["UBIQUITIN"]
TRAF3["TRAF3"] -->|"regulates"| TRAF6["TRAF6"]
TRAF3["TRAF3"] -->|"regulates"| NDP52["NDP52"]
TRAF3["TRAF3"] -->|"regulates"| AUTOPHAGY["AUTOPHAGY"]
TRAF3["TRAF3"] -.->|"inhibits"| LC3["LC3"]
TRAF3["TRAF3"] -->|"regulates"| Autophagy["Autophagy"]
TRAF3["TRAF3"] -.->|"inhibits"| Toll_Like_Receptor["Toll-Like Receptor"]
TRAF3["TRAF3"] ==>|"activates"| INFLAMMATION["INFLAMMATION"]
TRAF3["TRAF3"] -->|"regulates"| UBIQUITIN["UBIQUITIN"]
TRAF3["TRAF3"] ==>|"activates"| Als["Als"]
TRAF3["TRAF3"] ==>|"activates"| L

TRAF3

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">TRAF3</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TRAF3</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>TNF Receptor-Associated Factor 3</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>4p12</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>7188</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000126777</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y4K0</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein Coding</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>CAP-1, CAP1, RNF83</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/diabetes" style="color:#ef9a9a">Diabetes</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/lymphoma" style="color:#ef9a9a">Lymphoma</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">40 edges</a></td>
</tr>
</table>

TRAF3 (TNF Receptor-Associated Factor 3) is a crucial signaling adapter protein that regulates multiple innate immune signaling pathways, including [NF-kappaB](/mechanisms/nfkb-signaling-pathway), MAPK, and type I interferon responses. It plays dual roles in both promoting and inhibiting inflammation depending on cellular context and stimulus type, making it a key regulator of neuroinflammation in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis) [@chen2023].

Gene Information

Molecular Structure and Function

TRAF3 is a member of the TNF receptor-associated factor (TRAF) family of adapter proteins that mediate signaling from the TNF receptor superfamily and Toll-like receptor (TLR) family. The protein contains several functional domains:

Core Signaling Functions

TRAF3 regulates multiple critical signaling pathways:

NF-κB Signaling: TRAF3 negatively regulates non-canonical NF-κB signaling by targeting NIK (NF-κB-inducing kinase) for K48-linked ubiquitination and proteasomal degradation. This prevents constitutive activation of the non-canonical NF-κB pathway, which is crucial for controlling inflammatory gene expression in the brain. Loss of TRAF3 leads to NIK accumulation and aberrant NF-κB activation, resulting in heightened inflammatory responses [@liu2023].

Type I Interferon Response: TRAF3 is essential for RIG-I-like receptor (RLR)-mediated type I interferon production upon viral infection. It interacts with MAVS (Mitochondrial Antiviral-Signaling protein) to activate IRF3/IRF7-mediated transcription of interferon genes. This antiviral response has implications for understanding viral contributions to neurodegeneration [@gao2023].

TLR Signaling: TRAF3 modulates TLR-induced inflammatory responses by interacting with MyD88 and TRIF adaptor proteins. It regulates the balance between pro-inflammatory and anti-inflammatory responses following TLR activation, with context-dependent effects that vary by cell type and stimulus [@lee2019].

NLRP3 Inflammasome Regulation: TRAF3 directly interacts with NLRP3 and ASC to suppress inflammasome activation in microglia. This function is particularly relevant in neurodegenerative contexts where inflammasome activation contributes to pathology [@lin2016].

Expression Pattern in the Brain

TRAF3 is expressed throughout the central nervous system with cell-type-specific patterns:

• [Neurons](/cell-types/neurons): Moderate to high expression, particularly in cortical and hippocampal regions. Neuronal TRAF3 supports cell survival signaling and modulates responses to inflammatory challenges
• [Microglia](/cell-types/microglia-neuroinflammation): High expression, where it serves as a critical regulator of inflammatory responses. Microglial TRAF3 deficiency leads to hyperactive inflammatory phenotypes
• [Astrocytes](/entities/astrocytes): Moderate expression, involved in regulating astrocyte-mediated inflammatory signaling
• Oligodendrocytes: Low to moderate expression, with potential roles in myelination and white matter integrity
• [Endothelial Cells](/mechanisms/neurovascular-pathway): Expression in brain vasculature suggests roles in blood-brain barrier function

Disease Associations

Alzheimer's Disease

TRAF3 plays multifaceted roles in Alzheimer's disease pathogenesis:

Amyloid-β Interaction: TRAF3 modulates the inflammatory response to amyloid-β ([Aβ](/proteins/amyloid-beta)) plaques. Loss of TRAF3 function correlates with increased neuroinflammation around plaques. Studies show TRAF3 expression is significantly decreased in AD hippocampus and prefrontal cortex [@wang2020].

Tau Pathology: TRAF3 deficiency exacerbates tau pathology-induced neuroinflammation and accelerates cognitive decline in model systems. Restoring TRAF3 expression reduces inflammatory markers and improves neuronal function [@chen2023].

Therapeutic Targeting: Recent studies explore TRAF3-modulating compounds for AD treatment. Strategies include:

• Small molecules that enhance TRAF3 expression
• Gene therapy approaches to restore TRAF3 function
• Combinatorial treatments targeting both TRAF3 and other inflammatory pathways [@tang2024]

Parkinson's Disease

TRAF3 polymorphisms have been associated with PD susceptibility in multiple populations, with particularly significant findings in East Asian cohorts [@zhao2024]:

α-Synucleinopathy: TRAF3-mediated signaling influences α-synuclein aggregation and dopaminergic neuron viability. Microglial TRAF3 deficiency leads to enhanced neuroinflammation in PD models, accelerating dopaminergic neuron loss [@miao2024].

Substantia Nigra: Reduced TRAF3 expression in the substantia nigra pars compacta correlates with disease severity. This may contribute to microglial dysregulation and chronic neuroinflammation characteristic of PD.

LRRK2 Interaction: Studies suggest TRAF3 interacts with [LRRK2](/genes/lrrk2) signaling pathways, potentially linking genetic and inflammatory factors in PD pathogenesis.

Amyotrophic Lateral Sclerosis

TRAF3 is significantly downregulated in ALS motor cortex and spinal cord:

Motor Neuron Pathology: TRAF3 deficiency exacerbates motor neuron degeneration in ALS models. Loss of TRAF3 in microglia leads to hyperactivated inflammatory responses that harm surviving motor neurons [@xu2022].

Astrocyte Dysfunction: Altered TRAF3 expression in astrocytes contributes to non-cell-autonomous toxicity in ALS. Astrocytic TRAF3 deficiency promotes secretion of inflammatory mediators that harm motor neurons.

Therapeutic Potential: Restoring TRAF3 expression in glia represents a potential therapeutic approach for ALS [@wang2021].

Herpes Simplex Encephalitis

TRAF3 variants increase susceptibility to herpes simplex encephalitis, demonstrating its critical role in CNS antiviral immunity. This has implications for understanding the proposed link between herpesvirus infection and neurodegeneration [@huo2021].

Signaling Networks

TRAF3 interacts with numerous signaling pathways relevant to neurodegeneration:

TRAF3 Signaling in Neurodegeneration
graph LR
TNF["TNF Family Ligands"] --> TRAF3
TLR["TLR Ligands"] --> TRAF3
RLR["RLR Viral RNA"] --> TRAF3
TRAF3 --> NIK["NIK"]
TRAF3 --> MAVS["MAVS"]
TRAF3 --> MyD88["MyD88"]
NIK --> NFKB["Non-canonical NF-kappaB"]
MAVS --> IRF["IRF3/IRF7"]
MyD88 --> TLRNFKB["TLR-induced NF-kappaB"]
NFKB --> INFLAM["Inflammatory Genes"]
IRF --> IFN["Type I IFN"]
TLRNFKB --> INFLAM2["Inflammatory Genes"]
INFLAM --> NEURO["Neurodegeneration"]

Therapeutic Implications

Targeting Strategies

Biomarker Potential

TRAF3 expression levels in cerebrospinal fluid (CSF) or peripheral blood mononuclear cells may serve as biomarkers for:

• Disease progression in AD and PD
• Response to anti-inflammatory therapies
• Risk for herpes simplex encephalitis

Clinical Trials and Drug Development

Several TRAF3-targeted approaches are in development:

• Small-molecule TRAF3 expression enhancers
• Gene therapy vectors for TRAF3 delivery
• TLR antagonists that preserve TRAF3 function

See Also

• [TLR Signaling](/mechanisms/tlr-signaling-neurodegeneration)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [NF-κB Pathway](/mechanisms/nfkb-signaling-pathway)
• [Type I Interferon Response](/mechanisms/interferon-response-neurodegeneration)
• [Microglia](/cell-types/microglia-neuroinflammation)
• [TRAF6](/genes/traf6)
• [IRAK2](/genes/irak2)
• [MAP3K14 (NIK)](/genes/map3k14)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving TRAF3 discovered through SciDEX knowledge graph analysis: